Early-stage Parkinson's disease: Abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin-sensitive MRI

Previous pathologic studies evaluated the substantia nigra pars compacta (SNpc) of a limited number of idiopathic Parkinson's disease (IPD) patients with relatively longer disease durations. Therefore, it remains unknown which region of the SNpc is most significantly affected in early-stage IPD...

Full description

Bibliographic Details
Main Authors: Kim, E.Y (Author), Noh, Y. (Author), Sung, Y.H (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
Online Access:View Fulltext in Publisher
LEADER 04441nam a2200925Ia 4500
001 10.1002-hbm.25406
008 220427s2021 CNT 000 0 und d
020 |a 10659471 (ISSN) 
245 1 0 |a Early-stage Parkinson's disease: Abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin-sensitive MRI 
260 0 |b John Wiley and Sons Inc  |c 2021 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1002/hbm.25406 
520 3 |a Previous pathologic studies evaluated the substantia nigra pars compacta (SNpc) of a limited number of idiopathic Parkinson's disease (IPD) patients with relatively longer disease durations. Therefore, it remains unknown which region of the SNpc is most significantly affected in early-stage IPD. We hypothesized that a voxelwise analysis of thin-section neuromelanin-sensitive MRI (NM-MRI) may help determine the significantly affected regions of the SNpc in early-stage IPD and localize these areas in each nigrosome on high-spatial-resolution susceptibility map-weighted imaging (SMwI). Ninety-six healthy subjects and 50 early-stage IPD patients underwent both a 0.8 × 0.8 × 0.8 mm3 NM-MRI and a 0.5 × 0.5 × 1.0 mm3 multi-echo gradient-recalled echo imaging for SMwI. Both NM-MRI and SMwI templates were created by using image data from the 96 healthy subjects. Permutation-based nonparametric tests were conducted to investigate spatial differences between the two groups in NM-MRI, and the results were displayed on both NM-MRI and SMwI templates. The posterolateral and anteromedial regions of the SNpc in NM-MRI were significantly different between the two groups, corresponding to the nigrosome 1 and nigrosome 2 regions, respectively, on the SMwI template. There were the areas of significant spatial difference in the hypointense SN on SMwI between early-stage IPD patients and healthy subjects. These areas on SMwI were slightly greater than those on NM-MRI, including the areas showing group difference on NM-MRI. Our voxelwise analysis of NM-MRI suggests that two regions (nigrosome 1 and nigrosome 2) of the SNpc are separately affected in early-stage IPD. © 2021 The Authors. Human Brain Mapping published by Wiley Periodicals LLC. 
650 0 4 |a adult 
650 0 4 |a affine transform 
650 0 4 |a aged 
650 0 4 |a Aged 
650 0 4 |a anterior commissure 
650 0 4 |a Article 
650 0 4 |a brain stem 
650 0 4 |a cerebral peduncle 
650 0 4 |a clinical article 
650 0 4 |a Clinical Dementia Rating 
650 0 4 |a cohort analysis 
650 0 4 |a controlled study 
650 0 4 |a diagnostic imaging 
650 0 4 |a disease duration 
650 0 4 |a dopaminergic nerve cell 
650 0 4 |a female 
650 0 4 |a Female 
650 0 4 |a hand movement 
650 0 4 |a Hoehn and Yahr scale 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a least square analysis 
650 0 4 |a left handedness 
650 0 4 |a longitudinal study 
650 0 4 |a magnetic resonance imaging 
650 0 4 |a Magnetic Resonance Imaging 
650 0 4 |a male 
650 0 4 |a Male 
650 0 4 |a measurement accuracy 
650 0 4 |a melanin 
650 0 4 |a Melanins 
650 0 4 |a mesencephalon 
650 0 4 |a metabolism 
650 0 4 |a middle aged 
650 0 4 |a Middle Aged 
650 0 4 |a n (3 fluoropropyl) 2beta carboxymethoxy 3beta(4 iodophenyl)nortropane f 18 
650 0 4 |a neuromelanin 
650 0 4 |a neuromelanin 
650 0 4 |a neuromelanin 
650 0 4 |a neuroradiologist 
650 0 4 |a nigrosome 
650 0 4 |a nigrosome 1 
650 0 4 |a nigrosome 2 
650 0 4 |a nonparametric test 
650 0 4 |a nuclear magnetic resonance imaging 
650 0 4 |a Parkinson disease 
650 0 4 |a Parkinson disease 
650 0 4 |a Parkinson disease 
650 0 4 |a Parkinson Disease 
650 0 4 |a Pars Compacta 
650 0 4 |a posterior commissure 
650 0 4 |a priority journal 
650 0 4 |a red nucleus 
650 0 4 |a Retrospective Studies 
650 0 4 |a retrospective study 
650 0 4 |a right handedness 
650 0 4 |a rigidity 
650 0 4 |a substantia nigra pars compacta 
650 0 4 |a substantia nigra pars compacta 
650 0 4 |a substantia nigra pars compacta 
650 0 4 |a susceptibility weighted imaging 
650 0 4 |a tracer 
650 0 4 |a unclassified drug 
650 0 4 |a Unified Parkinson Disease Rating Scale 
700 1 |a Kim, E.Y.  |e author 
700 1 |a Noh, Y.  |e author 
700 1 |a Sung, Y.H.  |e author 
773 |t Human Brain Mapping